Pioglitazone induces dysplastic urothelial changes in urinary bladder of experimental diabetes
Pioglitazone induces dysplastic urothelial changes in urinary bladder of experimental diabetes
About this item
Full title
Author / Creator
Publisher
India: Wolters Kluwer India Pvt. Ltd
Journal title
Language
English
Formats
Publication information
Publisher
India: Wolters Kluwer India Pvt. Ltd
Subjects
More information
Scope and Contents
Contents
Objectives: Pioglitazone (PIO) is a widely prescribed oral antidiabetic drug that has concerns regarding a potential risk of developing carcinoma of the urinary bladder. The objective of the current study was to assess this potential risk. Materials and Methods: The potential risk of PIO-induced urinary bladder carcinoma was assessed in the current...
Alternative Titles
Full title
Pioglitazone induces dysplastic urothelial changes in urinary bladder of experimental diabetes
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10153741
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10153741
Other Identifiers
ISSN
2213-879X
E-ISSN
2213-8803
DOI
10.4103/jmau.jmau_34_21
